THYROIDPRINT Trademark

Trademark Overview

On Thursday, October 22, 2020, a trademark application was filed for THYROIDPRINT with the United States Patent and Trademark Office. The USPTO has given the THYROIDPRINT trademark a serial number of 90271801. The federal status of this trademark filing is REGISTERED as of Tuesday, January 16, 2024. This trademark is owned by GENEPRODX CHILE SPA. The THYROIDPRINT trademark is filed in the Pharmaceutical Products category with the following description:

Diagnostic kits consisting primarily of enzymes for medical purposes, buffers, and reagents for use in cancer testing; Medical diagnostic reagents
thyroidprint

General Information

Serial Number90271801
Word MarkTHYROIDPRINT
Filing DateThursday, October 22, 2020
Status700 - REGISTERED
Status DateTuesday, January 16, 2024
Registration Number7279712
Registration DateTuesday, January 16, 2024
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, August 31, 2021

Trademark Statements

Goods and ServicesDiagnostic kits consisting primarily of enzymes for medical purposes, buffers, and reagents for use in cancer testing; Medical diagnostic reagents

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, December 10, 2020
Primary Code005
First Use Anywhere DateFriday, June 30, 2023
First Use In Commerce DateFriday, June 30, 2023

Trademark Owner History

Party NameGENEPRODX CHILE SPA
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSantiago
CL
Party NameGENEPRODX CHILE SPA
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSantiago
CL
Party NameGENEPRODX CHILE SPA
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSantiago
CL

Trademark Events

Event DateEvent Description
Monday, January 22, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, January 16, 2024REGISTERED-PRINCIPAL REGISTER
Saturday, December 9, 2023NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Friday, December 8, 2023ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, October 20, 2023STATEMENT OF USE PROCESSING COMPLETE
Monday, October 9, 2023USE AMENDMENT FILED
Friday, October 20, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, October 9, 2023TEAS STATEMENT OF USE RECEIVED
Friday, April 28, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, April 26, 2023SOU EXTENSION 3 GRANTED
Wednesday, April 26, 2023SOU EXTENSION 3 FILED
Wednesday, April 26, 2023SOU TEAS EXTENSION RECEIVED
Thursday, October 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 25, 2022SOU EXTENSION 2 GRANTED
Tuesday, October 25, 2022SOU EXTENSION 2 FILED
Tuesday, October 25, 2022SOU TEAS EXTENSION RECEIVED
Saturday, October 30, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, October 28, 2021SOU EXTENSION 1 GRANTED
Thursday, October 28, 2021SOU EXTENSION 1 FILED
Thursday, October 28, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, October 26, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, August 31, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, August 31, 2021PUBLISHED FOR OPPOSITION
Wednesday, August 11, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, July 27, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, July 23, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, July 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, July 22, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Friday, April 9, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, April 9, 2021NON-FINAL ACTION E-MAILED
Friday, April 9, 2021NON-FINAL ACTION WRITTEN
Tuesday, March 23, 2021ASSIGNED TO EXAMINER
Thursday, December 10, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, October 26, 2020NEW APPLICATION ENTERED

Related Keywords

thyroidprint reagents diagnostic medical kits cancer testing buffers purposes enzymes consisting